CA2059363C - Benzo¬5,6|cyclohepta¬1,2-b|pyridine derivatives and antiallergic agents comprising same - Google Patents

Benzo¬5,6|cyclohepta¬1,2-b|pyridine derivatives and antiallergic agents comprising same

Info

Publication number
CA2059363C
CA2059363C CA002059363A CA2059363A CA2059363C CA 2059363 C CA2059363 C CA 2059363C CA 002059363 A CA002059363 A CA 002059363A CA 2059363 A CA2059363 A CA 2059363A CA 2059363 C CA2059363 C CA 2059363C
Authority
CA
Canada
Prior art keywords
benzo
dihydro
pyridine
cyclohepta
piperidylidene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA002059363A
Other languages
English (en)
French (fr)
Other versions
CA2059363A1 (en
Inventor
Haruyoshi Honda
Hiroyuki Mizuno
Kinichi Mogi
Yoshikuni Ito
Yasushi Kaneko
Naokata Taido
Susumu Sato
Tadayuki Kuraishi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SSP Co Ltd
Original Assignee
SSP Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SSP Co Ltd filed Critical SSP Co Ltd
Publication of CA2059363A1 publication Critical patent/CA2059363A1/en
Application granted granted Critical
Publication of CA2059363C publication Critical patent/CA2059363C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
CA002059363A 1991-01-18 1992-01-15 Benzo¬5,6|cyclohepta¬1,2-b|pyridine derivatives and antiallergic agents comprising same Expired - Fee Related CA2059363C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP1825191 1991-01-18
JP18251/1991 1991-01-18

Publications (2)

Publication Number Publication Date
CA2059363A1 CA2059363A1 (en) 1992-07-19
CA2059363C true CA2059363C (en) 1998-12-22

Family

ID=11966465

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002059363A Expired - Fee Related CA2059363C (en) 1991-01-18 1992-01-15 Benzo¬5,6|cyclohepta¬1,2-b|pyridine derivatives and antiallergic agents comprising same

Country Status (6)

Country Link
US (1) US5231101A (OSRAM)
EP (1) EP0495484A1 (OSRAM)
JP (1) JPH0676403B2 (OSRAM)
KR (1) KR920014799A (OSRAM)
CA (1) CA2059363C (OSRAM)
TW (1) TW207538B (OSRAM)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5721236A (en) * 1993-10-15 1998-02-24 Schering Corporation Tricyclic carbamate compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
US6075025A (en) * 1993-10-15 2000-06-13 Schering Corporation Tricyclic carbamate compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
US6365588B1 (en) 1993-10-15 2002-04-02 Schering Corporation Tricyclic amide and urea compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
IL111235A (en) * 1993-10-15 2001-03-19 Schering Plough Corp Medicinal preparations for inhibiting protein G activity and for the treatment of malignant diseases, containing tricyclic compounds, some such new compounds and a process for the preparation of some of them
US5719148A (en) * 1993-10-15 1998-02-17 Schering Corporation Tricyclic amide and urea compounds useful for inhibition of g-protein function and for treatment of proliferative diseases
US5661152A (en) * 1993-10-15 1997-08-26 Schering Corporation Tricyclic sulfonamide compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
US5700806A (en) * 1995-03-24 1997-12-23 Schering Corporation Tricyclic amide and urea compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
US5684013A (en) * 1995-03-24 1997-11-04 Schering Corporation Tricyclic compounds useful for inhibition of g-protein function and for treatment of proliferative diseases
US5712280A (en) * 1995-04-07 1998-01-27 Schering Corporation Tricyclic compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
US5801175A (en) * 1995-04-07 1998-09-01 Schering Corporation Tricyclic compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
US5891872A (en) * 1995-04-07 1999-04-06 Schering Corporation Tricyclic compounds
IL117798A (en) * 1995-04-07 2001-11-25 Schering Plough Corp Tricyclic compounds useful for inhibiting the function of protein - G and for the treatment of malignant diseases, and pharmaceutical preparations containing them
US5874442A (en) * 1995-12-22 1999-02-23 Schering-Plough Corporation Tricyclic amides useful for inhibition of G-protein function and for treatment of proliferative disease
JP2001521489A (ja) * 1996-09-13 2001-11-06 シェーリング コーポレイション ファルネシルタンパク質トランスフェラーゼインヒビターである三環式抗腫瘍性化合物
US6071907A (en) * 1996-09-13 2000-06-06 Schering Corporation Tricyclic compounds useful as FPT inhibitors
US6040305A (en) * 1996-09-13 2000-03-21 Schering Corporation Compounds useful for inhibition of farnesyl protein transferase
US5985879A (en) * 1996-09-13 1999-11-16 Schering Corporation Compounds useful for inhibition of farnesyl protein transferase
US5945429A (en) * 1996-09-13 1999-08-31 Schering Corporation Compounds useful for inhibition of farnesyl protein transferase
JP2002515052A (ja) * 1996-09-13 2002-05-21 シェーリング コーポレイション ファルネシルタンパク質トランスフェラーゼの阻害に有用な化合物
US6030982A (en) * 1996-09-13 2000-02-29 Schering Corporationm Compounds useful for inhibition of farnesyl protein transferase
IL128951A0 (en) * 1996-09-13 2000-02-17 Schering Corp Tricyclic compounds useful for inhibition of farnesyl protein transferase
US5994364A (en) 1996-09-13 1999-11-30 Schering Corporation Tricyclic antitumor farnesyl protein transferase inhibitors
US5861395A (en) * 1996-09-13 1999-01-19 Schering Corporation Compounds useful for inhibition of farnesyl proteins transferase
AU4337997A (en) * 1996-09-13 1998-04-02 Schering Corporation Tricyclic inhibitors of farnesyl protein transferase
US6130229A (en) * 1996-10-09 2000-10-10 Schering Corporation Tricyclic compounds having activity as RAS-FPT inhibitors
US6576639B1 (en) 1997-06-17 2003-06-10 Schering Corporation Compounds for the inhibition of farnesyl protein transferase
HUP0002659A3 (en) * 1997-06-17 2002-11-28 Schering Corp Benzo-5,6-cyclohepta[1,2-b]pyridine derivatives, pharmaceutical compositions containing them and their use
US6051582A (en) * 1997-06-17 2000-04-18 Schering Corporation Compounds useful for inhibition of farnesyl protein transferase
US6218401B1 (en) 1997-06-17 2001-04-17 Schering Corporation Phenyl-substituted tricyclic inhibitors of farnesyl-protein transferase
US6159984A (en) 1997-06-17 2000-12-12 Schering Corporation Farnesyl protein transferase inhibitors
US6228865B1 (en) 1997-06-17 2001-05-08 Schering Corporation Compounds useful for inhibition of farnesyl protein transferase
US6211193B1 (en) 1997-06-17 2001-04-03 Schering Corporation Compounds useful for inhibition of farnesyl protein transferase
US6689789B2 (en) 1997-06-17 2004-02-10 Schering Corporation Compounds useful for inhibition of farnesyl protein transferase
US6632455B2 (en) 1997-12-22 2003-10-14 Schering Corporation Molecular dispersion composition with enhanced bioavailability
US6147090A (en) * 1998-09-17 2000-11-14 Pfizer Inc. 4-carboxyamino-2-methyl-1,2,3,4,-tetrahydroquinolines
US6197786B1 (en) 1998-09-17 2001-03-06 Pfizer Inc 4-Carboxyamino-2-substituted-1,2,3,4-tetrahydroquinolines
US6147089A (en) * 1998-09-17 2000-11-14 Pfizer Inc. Annulated 4-carboxyamino-2-methyl-1,2,3,4,-tetrahydroquinolines
GT199900147A (es) 1998-09-17 1999-09-06 1, 2, 3, 4- tetrahidroquinolinas 2-sustituidas 4-amino sustituidas.
US6140342A (en) * 1998-09-17 2000-10-31 Pfizer Inc. Oxy substituted 4-carboxyamino-2-methyl-1,2,3,4-tetrahydroquinolines
WO2003087059A2 (en) * 2002-04-08 2003-10-23 Sun Pharmaceutical Industries Limited (e)-oxime ether derivative of 5,6-dihydro-benzo[5,6]cyclohepta[1,2-b]pyridin-11-one
CN104418836A (zh) * 2013-09-09 2015-03-18 天津药物研究院 双酰胺类化合物及其制备方法和用途
CN113880801A (zh) * 2020-07-03 2022-01-04 合肥医工医药股份有限公司 一类三环化合物、其制备方法及其医药用途
CN115385892A (zh) * 2021-10-28 2022-11-25 天津市昕晨投资发展有限公司 地氯雷他定衍生物、其制备方法及其用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4355036A (en) * 1980-06-19 1982-10-19 Schering Corporation Tricyclic-substituted piperidine antihistamines
US4282233B1 (en) * 1980-06-19 2000-09-05 Schering Corp Antihistaminic 11-(4-piperidylidene)-5h-benzoÄ5,6Ü-cyclohepta-Ä1,2Ü-pyridines
US4826853A (en) * 1986-10-31 1989-05-02 Schering Corporation 6,11-Dihydro-11-(N-substituted-4-piperidylidene)-5H-benzo(5,6)cyclohepta(1,2-B)pyridines and compositions and methods of use
US4863931A (en) * 1988-09-15 1989-09-05 Schering Corporation Antihistaminic fluoro substituted benzocycloheptapyridines

Also Published As

Publication number Publication date
EP0495484A1 (en) 1992-07-22
CA2059363A1 (en) 1992-07-19
JPH0676403B2 (ja) 1994-09-28
KR920014799A (ko) 1992-08-25
JPH0559040A (ja) 1993-03-09
TW207538B (OSRAM) 1993-06-11
US5231101A (en) 1993-07-27

Similar Documents

Publication Publication Date Title
CA2059363C (en) Benzo¬5,6|cyclohepta¬1,2-b|pyridine derivatives and antiallergic agents comprising same
KR910002583B1 (ko) 피페라진 유도체 또는 이의 염, 이의 제조방법 및 활성 성분으로서 이를 함유하는 약제학적 조성물
US5922733A (en) Pyridil carboxamides as 5HT2B/2C receptor antagonists
RU2685234C1 (ru) Конденсированные бициклические гетероароматические производные в качестве модуляторов активности tnf
EP0182165B1 (en) Thienyl condensed-pyrazole derivatives
EA005289B1 (ru) Гетероциклические соединения, содержащие тетрагидропиридиновые или пиперидиновые группы, в качестве антагонистов рецепторов кортикотропин-рилизинг-фактора
JP2003513099A (ja) ピラゾールカルボン酸の三環式誘導体、その製造法およびそれを含む医薬組成物
NO834798L (no) Medikamenter paa basis av derivater av naftalen- eller aza-naftalencarboxamid, nye slike derivater og deres fremstilling
RU2411237C2 (ru) ПРОИЗВОДНЫЕ ПИРИДИН-2-КАРБОКСАМИДА В КАЧЕСТВЕ АНТАГОНИСТОВ mGluR5
IL94433A (en) Pharmaceutical compositions containing aminophenol derivatives, some such novel compounds and their preparation.
KR960002852B1 (ko) 헤테로아릴 3-옥소-프로판니트릴 유도체, 이의 제조방법 및 이를 함유하는 약제학적 조성물
EP0343574B1 (en) 4(1H)-quinolone derivatives
EP0788499A1 (en) Cns-active pyridinylurea derivatives
WO1997008167A1 (en) 5ht2c and 5ht2b antagonists
EP0691973A1 (en) THIENO-INDOLE DERIVATIVES AS 5HT2c AND 5HT2b ANTAGONISTS
CN102666548B (zh) 三环抗生素
JPH05246980A (ja) β−オキソ−β−ベンゼンプロパンチオアミド誘導体
HUT71132A (en) Bis-aryl-carbinol derivatives, pharmaceutical compositions containing them and process for producing
US4874760A (en) 4,7-dihydroisothiazolo(5,4-b)pyridine derivatives and cardiovascular treating agents containing said derivatives
EP0912554B1 (en) Indoline derivatives useful as 5-ht-2c receptor antagonists
JPH05202054A (ja) アミノメチル置換２，３−ジヒドロピラノ〔２，３−ｂ〕ピリジン類
US4622326A (en) 6H-isoxazolo(5,4-d)pyrazolo(3,4-b)pyridines, and their use as antihypertensive and analgesic agents
CA2290475A1 (en) Indoline derivatives as 5ht2c receptor antagonists
US6166034A (en) Spiro piperidine derivatives as 5HT1D receptor antagonists
US20090149495A1 (en) Compounds

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed